Abstract:BACKGROUND/PURPOSE:Recent progress in cancer immunology provides more insight in immune evasion of cancer cells. Cancer cells may achieve immune evasion through several ways including ineffective antigen presentation, T cell checkpoint utilization, immunosuppressive cytokines secretion and immunosuppressive cells recruitment. However, few literatures mentioned about the change of peripheral blood immune cells in advanced hepatocellular carcinoma (HCC) patients. To answer this question, we initiated a pilot study through detailed flow cytometry.METHODS:We enrolled patients with advanced HCC patients who had informed consent to the collection of their peripheral blood. We also recruited healthy individuals for the control group. Using flow cytometry, we analyzed lymphocyte subclasses and the PD-1 or PD-L1 positivity of immune cells in peripheral blood from HCC patients and healthy individuals.RESULTS:Twenty-four HCC patients were enrolled and twenty healthy individuals were enrolled. Most of the HCC patients were HBV carrier (58.3%), and the mean age was 61 years old. Among 55 immune cell parameters we examined in peripheral blood, 16 were significantly different between advanced HCC patients and healthy individuals by univariate analysis. Multivariate analysis was then conducted by fitting logistic regression model and showed that CD69-CD25- Naïve CD4αβT cell percentage and dendritic cell percentage can reasonably predict the advanced HCC status from peripheral blood. By our regression model, the adjusted generalized R2 = 0.918 and the estimated area under the Receiver Operating Characteristic (ROC) curve was 0.99.CONCLUSION:CD69-CD25- Naïve CD4αβT cell percentage and dendritic cell percentage in peripheral blood are highly correlated with the advanced HCC status. The change may result from immune evasion initiated by hepatocellular carcinoma cells and further investigation is warranted. Validation study is ongoing and this mechanism may be utilized to treat advanced HCC patient in the future.

[Establishment of 2-Dimensional Electrophoresis Maps of Peripheral Blood Mononuclear Cells].

Mass Spectrometric Analysis of Peripheral Blood Mononuclear Cells in HCV Infected Patients

Proteome Analysis of Hepatocellular Carcinoma by Two-dimensional Difference Gel Electrophoresis

The Unique Characteristic in Peripheral Immune Cells in Patients with Advanced Hepatocellular Carcinoma.

Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray.

Proteomic Analysis of Individual Variation in Normal Livers of Human Beings Using Difference Gel Electrophoresis

Genes Expression Profiling of Peripheral Blood Cells of Patients with Hepatocellular Carcinoma

Analysis of Low Abundance Diferential Proteins in Plasma from Hepatocellular Carcinomas Patients by Multi-dimensional Chromatography Tandem Mass Spectrometry

Comparative Proteomics Study on HepG2 Human Hepatocellular Carcinoma Cells and 7702 Human Normal Hepatocytes

Proteomic Profiling of N-linked Glycoproteins Involved in Hepatocellular Carcinoma by Two-dimensional Electrophoresis and Mass Spectrometry

Proteomic and Phosphor-Proteomic Signatures of Clinical Hepatitis B Virus-Associated Hepatocellular Carcinoma

Expression of Transforming Growth Factor Β 1 in Patients with Hepatocellular Carcinoma and Its Clinical Value

Identification of the Level of Exosomal Protein by Parallel Reaction Monitoring Technology in HCC Patients

Screening Hepatocellular Carcinoma Autoantibodies by Serological Proteome Analysis

RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma

Proteomic Analysis of Peripheral Blood Mononuclear Cells to Identify Potential Markers of Fibrosis in Chronic Hepatitis B

Proteomic Expression Signature Distinguishes Cancerous and Nonmalignant Tissues in Hepatocellular Carcinoma.

Preliminary study on proteomic patterns in hepatic tissue to identify HBV related hepatic firbrosis.

Proteomic Analysis on Metastasis-Associated Proteins of Human Hepatocellular Carcinoma Tissues

A Comprehensive Proteome Analysis of Peripheral Blood Mononuclear Cells (pbmcs) to Identify Candidate Biomarkers of Pancreatic Cancer

Proteomic Analysis of Hepatitis B Virus-Associated Hepatocellular Carcinoma: Identification of Potential Tumor Markers